← FDA DRUG APPROVALS

FDA ANDA · ANDA076448

TOPIRAMATE

Sponsor: BARR

APPLICATION
ANDA076448
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-17
LATEST ACTION
2003-12-17
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TOPIRAMATEDiscontinued
TOPIRAMATE 15MG · CAPSULE · ORAL
TOPIRAMATEDiscontinued
TOPIRAMATE 25MG · CAPSULE · ORAL

Approval history

2003-12-17OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →